Your browser doesn't support javascript.
loading
MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation.
Zhenhai, Zou; Qi, Cheng; Shuchao, Zhang; Zhongqi, Wang; Xue, Song; Zhijun, Geng; Zhijie, Mei; Jianmin, Liu; Beibei, Liu; Yuanyuan, Guo.
Afiliação
  • Zhenhai Z; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China.
  • Qi C; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China.
  • Shuchao Z; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China.
  • Zhongqi W; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China.
  • Xue S; The Central Laboratory of the First Affiliated Hospital of Bengbu Medical College, Anhui, Bengbu, 233040, China.
  • Zhijun G; The Central Laboratory of the First Affiliated Hospital of Bengbu Medical College, Anhui, Bengbu, 233040, China.
  • Zhijie M; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China.
  • Jianmin L; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China.
  • Beibei L; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China. bb_dynasty@qq.com.
  • Yuanyuan G; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, 233040, Anhui, Bengbu, Longzihu, Bengbu, China. guoshaohua111@163.com.
BMC Cancer ; 23(1): 956, 2023 Oct 09.
Article em En | MEDLINE | ID: mdl-37814205
MicroRNAs (miRNAs) have been reported to serve as potential biomarkers in bladder cancer and play important roles in cancer progression. This study aimed to investigate the biological role of miR-205-3p in bladder cancer. We showed that miR-205-3p was significantly down-regulated in bladder cancer tissues and cells. Moreover, overexpression of miR-205-3p inhibited bladder cancer progression in vitro. Then we confirmed that GLO1, a downstream target of miR-205-3p, mediated the effect of miR-205-3p on bladder cancer cells. In addition, we found that miR-205-3p inhibits P38/ERK activation through repressing GLO1. Eventually, we confirmed that miR-205-3p inhibits the occurrence and progress of bladder cancer by targeting GLO1 in vivo by nude mouse tumorigenesis and immunohistochemistry. In a word, miR-205-3p inhibits proliferation and metastasis of bladder cancer cells by activating the GLO1 mediated P38/ERK signaling pathway and that may be a potential therapeutic target for bladder cancer.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / MicroRNAs / Lactoilglutationa Liase Limite: Animals / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / MicroRNAs / Lactoilglutationa Liase Limite: Animals / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China